Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children. [electronic resource]
Producer: 20120402Description: 1287-95 p. digitalISSN:- 2040-2058
- Anti-HIV Agents -- blood
- Area Under Curve
- Aryl Hydrocarbon Hydroxylases -- analysis
- Biological Availability
- Body Weight
- Child
- Child, Preschool
- Cytochrome P-450 CYP2B6
- Drug Administration Schedule
- Drug Combinations
- Drug Dosage Calculations
- Drug Therapy, Combination -- methods
- Drug-Related Side Effects and Adverse Reactions
- Female
- HIV -- drug effects
- HIV Infections -- blood
- Humans
- Infant
- Lamivudine -- blood
- Male
- Nevirapine -- blood
- Oxidoreductases, N-Demethylating -- analysis
- Reverse Transcriptase Inhibitors -- blood
- Tablets
- Zidovudine -- blood
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.